fig2

From: 3,3'-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs

3,3'-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs

Figure 2. Structures of 3,3’-diindolylmethane (DIM) derivatives (halo-, phenyl, and ferrocenyl derivatives) with anti-tumor activities associated with circumvention of cancer resistance. Cell lines (in parentheses): MDA-MB-231 breast cancer, SW480 colon cancer, 518A2 melanoma, LNCaP prostate cancer, C4-2B prostate cancer, PC3 prostate cancer, KB-V1/Vbl cervix cancer, HT-29 colon cancer, HCT-116 colon cancer, Panc-1 pancreas cancer, and BxPC-3 pancreas cancer cells

fig2

Committee on Publication Ethics

Portico

Committee on Publication Ethics

Portico